Serina Therapeutics, Inc. (SER) Return on equity 2017–2024
Serina Therapeutics, Inc. (SER) return on equity by fiscal year — reported net income divided by year-end shareholders’ equity.
-1738.1%FY2024 · since FY2017: -90.4% → -1738.1%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2024 | -1738.1% | — |
| FY2019 | -548.0% | -447.2 pp |
| FY2018 | -100.7% | -10.4 pp |
| FY2017 | -90.4% | — |
ROE = reported net income ÷ reported year-end shareholders’ equity for the same fiscal year. Heavy buybacks shrink equity and can push ROE very high (or negative-equity years drop out).
Source: SEC XBRL filings · For reference only · Not investment advice